tiprankstipranks
Fate Therapeutics (FATE)
NASDAQ:FATE
US Market
FATE
Fate Therapeutics
RESEARCH TOOLSreports
Want to see FATE full AI Analyst Report?

Fate Therapeutics (FATE) Stock News & Sentiment

1,273 Followers
Gil Blum Maintains Hold Rating Amid Uncertainty on FT819 Durability and Rising Competition in Lupus Nephritis Cell Therapies
Premium
Ratings
Gil Blum Maintains Hold Rating Amid Uncertainty on FT819 Durability and Rising Competition in Lupus Nephritis Cell Therapies
3d ago
FATE
Tara Bancroft Reiterates Hold Rating as FT819’s Autoimmune Momentum Offsets Early-Stage, Regulatory and Execution Risks
Premium
Ratings
Tara Bancroft Reiterates Hold Rating as FT819’s Autoimmune Momentum Offsets Early-Stage, Regulatory and Execution Risks
3d ago
FATE
FATE Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
FATE Upcoming Earnings Report: What to Expect?
13d ago
FATE
Maintaining a Hold on Fate Therapeutics as FT819’s Clinical and Commercial Profile Remains Unclear
Premium
Ratings
Maintaining a Hold on Fate Therapeutics as FT819’s Clinical and Commercial Profile Remains Unclear
3M ago
FATE
Fate Therapeutics Reports Q3 Loss Amid Restructuring Efforts
Premium
Company Announcements
Fate Therapeutics Reports Q3 Loss Amid Restructuring Efforts
6M ago
FATE
Navigating Data Privacy Challenges: Fate Therapeutics’ Battle with Regulatory Compliance and Business Risks
Premium
Company Announcements
Navigating Data Privacy Challenges: Fate Therapeutics’ Battle with Regulatory Compliance and Business Risks
6M ago
FATE
Fate Therapeutics: Balancing Potential and Uncertainty with FT819’s Promise in Autoimmune Treatment
Premium
Ratings
Fate Therapeutics: Balancing Potential and Uncertainty with FT819’s Promise in Autoimmune Treatment
6M ago
FATE
More FATE News >

FATE News on the Web

Fate Therapeutics announces data presentation of FT839
TipRanks News
Bullish
Bank of America Securities Sticks to Their Hold Rating for Fate Therapeutics (FATE)
TipRanks News
Neutral
Maintaining a Hold on Fate Therapeutics as FT819’s Clinical and Commercial Profile Remains Unclear
TipRanks News
Neutral
Analysts Offer Insights on Healthcare Companies: BioCryst (BCRX) and Fate Therapeutics (FATE)
TipRanks News
Bearish
Fate Therapeutics (FATE) Reports Q4 Loss, Misses Revenue Estimates
Zacks
Neutral
Fate Therapeutics reports Q4 EPS (77c), consensus (27c)
TipRanks News
Bullish
Why Fate Therapeutics, Inc.’s (FATE) Stock Is Up 6.19%
AAII
Neutral
Top Fate Therapeutics Insider Makes a Quiet Move That Investors Can’t Ignore
TipRanks News
Bearish

News Score - Last 7 Days

Neutral
FATE
Sector Average
Media Buzz
This Week1 articles
Weekly Average0 articles
News Sentiment
This Week100%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is FATE’s Media Buzz Sentiment?
Currently, no data Available
What is FATE’s weekly average amount of articles?
Currently, no data Available
What is FATE’s News Sentiment?
100% of articles about FATE were positive this week, compared to its sector average of 70%.
    Healthcare Stocks that are Trending in the News
    TVTXTravere Therapeutics
    HVOOpen Orphan Plc
    PBMPsyence Biomedical
    QDELQuidelOrtho
    Showing the stocks with the most bullish news sentiment over the past week